Unrivaled Preclinical Huntington’s Disease Studies

Distinguished by the experience and knowledge of our scientists and technicians, PsychoGenics stands as a leading partner in preclinical Huntington’s disease studies.

Huntington’s disease arises from an unstable expansion of CAG repeats within the gene encoding the huntingtin (Htt) protein. This genetic anomaly results in an excessive accumulation of glutamine repeats, forming aggregates in the nucleus that contribute to the progressive nature of the disease. This devastating neurodegenerative disorder is characterized by abnormal motor movements, personality changes, and premature death.

Our Huntington’s Disease Models

Our preclinical Huntington’s disease research expertise encompasses the leading mouse models for drug discovery and development in the field: